Advancing Transformative Therapies Through Science

Therapeutic Areas

We're committed to improving the lives of people around the world impacted by life-threatening conditions across virology, oncology and inflammation.

Virology
Our leadership in virology has transformed the landscape of HIV and viral hepatitis — and we’re not done yet.
Learn More
Oncology
We’re innovating next-generation therapies, expanding access to care and advancing collaborations to transform how cancer is treated.
Learn More
Inflammation
We’re poised to improve the lives of people living with inflammatory diseases by delivering therapies that offer long-acting remissions or cures.
Learn More

11K+

Employees in research & development and Pharmaceutical Development and Manufacturing

$5B

Invested in research and development in 2022

4.2M

Square feet of laboratory, manufacturing and related space as of 2023

RESEARCH

PIPELINE

50

Clinical stage programs and 13 clinical-stage potential opt-in assets

MEDICINES

25+

Therapies in the U.S. and a growing portfolio

clinical trials

We're committed to involving the communities most impacted by disease in the design and execution of our clinical trials.

Stories@Gilead

Follow our journey to create a healthier world for all people

Scientific Innovation
Designing Inclusive Clinical Trials in an Effort to Upend the HIV Epidemic
November 07, 2024
People and Culture
Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer
October 14, 2024
Access and Health Equity
New Report Shows Every Country in the World Must Do More to End the HIV Epidemic
September 30, 2024
Scientific Innovation
Working to Build Next-Generation Cancer Therapies
September 10, 2024
Access and Health Equity
Championing HIV Services for LGBTQ+ Youth
September 05, 2024